Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGFβRII Inhibition

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Tumor-derived exosomes contain various microRNAs (miRNAs), including oncogenic and tumor suppressor types.
• miR-302b can inhibit cancer progression by targeting oncogenes post-transcriptionally.
• The role of exosomal miR-302b in regulating lung cancer cell proliferation is not well understood.

Purpose of the Study:

• To investigate the effect of exosome-derived miR-302b on lung cancer cell proliferation and migration.
• To elucidate the underlying molecular mechanism of exosomal miR-302b action in lung cancer.

Main Methods:

• Assessed lung cancer cell proliferation and migration using MTT and Transwell assays.
• Quantified miR-302b levels in exosomes via qRT-PCR.
• Analyzed the expression of phosphorylated ERK1/2, MMP9, and TGFβRII using Western blot.
• Investigated miR-302b targets using Luciferase reporter assays.

Main Results:

• Exosomes from 95C cells, with higher metastatic potential, significantly reduced 95D cell migration.
• miR-302b was notably overexpressed in 95C cells and their derived exosomes compared to 95D cells.
• Transfection with miR-302b suppressed 95D cell proliferation and migration, downregulating TGFβRII, phosphorylated ERK1/2, and MMP9.

Conclusions:

• Exosome-derived miR-302b inhibits lung cancer cell proliferation and migration.
• The mechanism involves the TGFβRII/ERK signaling pathway.
• Exosomal miR-302b represents a potential therapeutic target for lung cancer.